Ars Pharmaceuticals Inc (SPRY)
SG&A Expense Growth
7.44%
Quarterly · Period ending:
SPRY SG&A Expense Growth
Latest reported7.44%period ending
Latest reported7.44%period ending
SPRY Quarterly SG&A Growth (QoQ) (0.00% → 7.44%)
Latest values, visible window
High-resolution chart · PNG
SPRY sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 7.4442% | |
| 20.4303% | |
| -19.7937% | |
| 37.6326% | |
| 0% | |
| 0% | |
| -100% | |
| 115.5747% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| 9.1523% | |
| 13.3666% | |
| 257.9974% | |
| 23.1082% | |
| 5.0876% | |
| 29.8723% | |
| 76.2231% | |
| 9.6567% | |
| 0% | |
| -76.6299% | |
| 0% | |
| 89.3993% | |
| 115.2091% | |
| 0% |